UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal

European journal of cancer (1990), 2009-05, Vol.45 (8), p.1370-1380

2009

Volltextzugriff (PDF)

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Blood, 2004-11, Vol.104 (9), p.2940-2942

2004

Volltextzugriff (PDF)

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Clinical cancer research, 2001-08, Vol.7 (8), p.2182-2194

2001

Volltextzugriff (PDF)

Mismatch repair and treatment resistance in ovarian cancer

BMC cancer, 2006-07, Vol.6 (1), p.201-201, Article 201

2006

Volltextzugriff (PDF)

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations

Journal of clinical oncology, 2002-01, Vol.20 (1), p.81-87

Mathijssen, R. H.J.

2002

Volltextzugriff (PDF)

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Journal of clinical oncology, 2001-09, Vol.19 (17), p.3733-3739

2001

Volltextzugriff (PDF)

Influence of Cremophor EL on the Bioavailability of Intraperitoneal Paclitaxel

Clinical cancer research, 2002-04, Vol.8 (4), p.1237-1241

2002

Volltextzugriff (PDF)

Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-γ, Tumor Necrosis Factor-α, IL-6, and IL-8 Responses

Clinical cancer research, 2003-01, Vol.9 (1), p.76-83

2003

Volltextzugriff (PDF)

Randomized Cross-Over Evaluation of Body-Surface Area–Based Dosing Versus Flat-Fixed Dosing of Paclitaxel

Journal of clinical oncology, 2003-01, Vol.21 (2), p.197-202

2003

Volltextzugriff (PDF)

Role of Intestinal P-glycoprotein in the Plasma and Fecal Disposition of Docetaxel in Humans

Clinical cancer research, 2000-07, Vol.6 (7), p.2598-2603

2000

Volltextzugriff (PDF)

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.309-318

2001

Volltextzugriff (PDF)

Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area Values

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1499-1506

2006

Volltextzugriff (PDF)

Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1

Neoplasia (New York, N.Y.), 2004-07, Vol.6 (4), p.297-301

2004

Volltextzugriff (PDF)

Impaired cisplatin influx in an A2780 mutant cell line: Evidence for a putative, cis-configuration-specific, platinum influx transporter

Cancer biology & therapy, 2006-08, Vol.5 (8), p.943-949

2006

Volltextzugriff (PDF)

Analgesic Adherence Measurement in Cancer Patients: Comparison Between Electronic Monitoring and Diary

Journal of pain and symptom management, 2007-12, Vol.34 (6), p.639-647

2007

Volltextzugriff (PDF)

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

Journal of clinical oncology, 2006-05, Vol.24 (13), p.e20-e22

2006

Volltextzugriff (PDF)

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Clinical cancer research, 1999-12, Vol.5 (12), p.3983-3989

1999

Volltextzugriff (PDF)

Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell Kill

Molecular pharmacology, 2003-08, Vol.64 (2), p.259-268

2003

Volltextzugriff (PDF)

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon‐α: Course and relationship with psychiatric status

Psychiatry and clinical neurosciences, 2008-10, Vol.62 (5), p.597-602

2008

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients with Metastatic Esophageal Cancer

Clinical cancer research, 2004-03, Vol.10 (6), p.1928-1934

2004

Volltextzugriff (PDF)

Determination of Doxorubicin and Doxorubicinol in Plasma of Cancer Patients by High-Performance Liquid Chromatography

Analytical biochemistry, 1999-01, Vol.266 (2), p.216-221

1999

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Brostallicin (PNU-166196), a New DNA Minor-Groove Binder, Administered Intravenously Every 3 Weeks to Adult Patients with Metastatic Cancer

Clinical cancer research, 2003-08, Vol.9 (8), p.2957-2964

2003

Volltextzugriff (PDF)

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

Cancer Immunology, Immunotherapy, 2005-01, Vol.54 (1), p.37-43

2005

Volltextzugriff (PDF)

RNA Expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response

Clinical cancer research, 2003-02, Vol.9 (2), p.827-836

2003

Volltextzugriff (PDF)

Docetaxel (Taxotere): Single agent activity, development of combination treatment and reducing side-effects

Cancer treatment reviews, 1995-09, Vol.21 (5), p.463-478

1995

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(126)

Sprache

Englisch
(126)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Humans
(106)
Life Sciences & Biomedicine
(100)
Science & Technology
(100)
Biological And Medical Sciences
(74)
Medical Sciences
(74)
Oncology
(66)
Pharmacology. Drug Treatments
(64)
Female
(61)
Antineoplastic Agents
(53)
Middle Aged
(53)
Adult
(52)
Male
(52)
Aged
(51)
Chemotherapy
(36)
Pharmacology & Pharmacy
(18)
Biochemistry & Molecular Biology
(16)
Neoplasms - Drug Therapy
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Dose-Response Relationship, Drug
(15)
Drug Administration Schedule
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Clinical Pharmacokinetics and Metabolism of Irinotecan (CPT-11)

Mismatch repair and treatment resistance in ovarian cancer

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations

Body-Surface Area–Based Dosing Does Not Increase Accuracy of Predicting Cisplatin Exposure

Influence of Cremophor EL on the Bioavailability of Intraperitoneal Paclitaxel

Repeated Administrations of Interleukin (IL)-12 Are Associated with Persistently Elevated Plasma Levels of IL-10 and Declining IFN-γ, Tumor Necrosis Factor-α, IL-6, and IL-8 Responses

Randomized Cross-Over Evaluation of Body-Surface Area–Based Dosing Versus Flat-Fixed Dosing of Paclitaxel

Role of Intestinal P-glycoprotein in the Plasma and Fecal Disposition of Docetaxel in Humans

Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

Evaluation of an Alternate Dosing Strategy for Cisplatin in Patients With Extreme Body Surface Area Values

Resistance to Platinum-Containing Chemotherapy in Testicular Germ Cell Tumors Is Associated with Downregulation of the Protein Kinase SRPK1

Impaired cisplatin influx in an A2780 mutant cell line: Evidence for a putative, cis-configuration-specific, platinum influx transporter

Analgesic Adherence Measurement in Cancer Patients: Comparison Between Electronic Monitoring and Diary

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience

Phase I Study of Subcutaneously Administered Recombinant Human Interleukin 12 in Patients with Advanced Renal Cell Cancer

Anticancer Drug Resistance Induced by Disruption of the Saccharomyces cerevisiae NPR2 Gene: a Novel Component Involved in Cisplatin- and Doxorubicin-Provoked Cell Kill

Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon‐α: Course and relationship with psychiatric status

A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients with Metastatic Esophageal Cancer

Determination of Doxorubicin and Doxorubicinol in Plasma of Cancer Patients by High-Performance Liquid Chromatography

Phase I and Pharmacokinetic Study of Brostallicin (PNU-166196), a New DNA Minor-Groove Binder, Administered Intravenously Every 3 Weeks to Adult Patients with Metastatic Cancer

Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant

RNA Expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response

Docetaxel (Taxotere): Single agent activity, development of combination treatment and reducing side-effects

Suchergebnisse filtern